MedTrace Logo

GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.

NCT00439920 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2018-10-23

No results posted yet for this study

Summary

The present study aims at verifying the state of the art in what this illness concerns and at organizing a centralized samples analysis.

Conditions

Interventions

DRUG

High-dose anthracycline

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Franco Mandelli, Prof. · Università degli Studi di Roma "La Sapienza"

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00439920 on ClinicalTrials.gov